Authorize participation in the Secondary Manufacturers’ Settlements with Alvogen, Inc., Apotex Corp., Amneal Pharmace...

Staff Report & Agenda Item Details

2025-1019 Authorize participation in the Secondary Manufacturers’ Settlements with Alvogen, Inc., Apotex Corp., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Indivior Inc., Viatris Inc. (“Mylan”), Sun Pharmaceutical Industries, Inc. and Zydus Pharmaceuticals (USA) Inc.) and settlement of respective claims in County of Dallas v. Purdue Pharma, et al., MDL Pretrial Cause No. 2018-77098, in the 152nd District Court of Harris County, Texas; In re Texas Opioid Litigation, Master File Cause No. 2018-63587, in the 152nd District Court of Harris County, Texas On a motion made by Commissioner Dr. Elba Garcia, and seconded by Commissioner Andrew Sommerman, the following order was passed and adopted by the Commissioners Court of Dallas County, State of Texas: BRIEFING DATE: September 16, 2025 FUNDING SOURCE: N/A Be it resolved and ordered that the Dallas County Commissioners Court does hereby approve the combined settlement participation and release forms with Secondary Manufacturers’ Settlements involving Alvogen, Inc., Apotex Corp., Indivior Inc., Viatris Inc. (“Mylan”), Sun Pharmaceutical Industries, Inc. and Zydus Pharmaceuticals (USA) Inc., including the resolution of its claims against Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., in County of Dallas v. Purdue Pharma, et al ., MDL Pretrial Cause No. 2018-77098, in the 152nd District Court of Harris County, Texas; In re Texas Opioid Litigation , Master File Cause No. 2018-63587, in the 152nd District Court of Harris County, Texas (the “Lawsuit”): WHEREAS, Dallas County obtained information indicating that certain drug companies and their corporate affiliates, parents, subsidiaries, and such other defendants as may be added to the litigation, including Alvogen, Inc., Apotex Corp., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., Indivior Inc., Viatris Inc. (“Mylan”), Sun Pharmaceutical Industries, Inc. and Zydus Pharmaceuticals (USA) Inc., (collectively, "Defendants") have engaged in fraudulent and/or reckless marketing and/or distribution of opioids that have resulted in addictions and overdoses; and